LGALS3 and metastatic malignant neoplasm in the lymph nodes: Patients with no or low level of Gal3 expression in their primary tumors were less likely to present with advanced stages (p = 0.0028), LVSI (lymphovascular space invasion) (p = 0.0053), cervical involvement (p = 0.0171), and pelvic and paraaortic lymph node metastases (pelvic: p = 0.0067, paraaortic: p = 0.0332).